Carolin Anders, Preetha Moorthy, Laura Svensson, Julia Müller, Oliver Heinze, Petra Knaup, Markus Wallwiener, Thomas M Deutsch, Thao-Vy Le, Lina Weinert
BACKGROUND: Early identification of quality of life (QoL) loss and side effects is a key challenge in breast cancer therapy. Digital tools can be helpful components of therapeutic support. Enable, a smartphone app, was used in a multicenter, prospective randomized controlled trial in 3 breast cancer centers. The app simultaneously serves as a therapy companion (eg, by displaying appointments), a tool for documenting QoL (eg, by enabling data collection for QoL questionnaires), and documentation of patient-reported side effects...
March 5, 2024: JMIR Human Factors